The largest database of trusted experimental protocols

8 protocols using cd271 pe

1

Phenotypic profiling of MSCs and ECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Phenotypic characterisation was performed on culture expanded MSCs at different passages and on cultured ECs at p4 using: CD31-FITC (#MCA1738F), CD105-PE (#MCA1557PE), CD90-PE (#MCA90PE) (all from Serotec, Kidlington, UK), CD73-PE (#550257), CD146-PE (#550315) (both from BD Pharmingen, Oxford, UK), and CD271-PE (#130-091-885, Miltenyi Biotec). The isotype controls were IgG1-FITC (#550616, BD Pharmingen) and IgG1-PE (#MCA928PE, Serotec). A total of 2×10
5 cells was stained with 5 μl FITC- or PE-conjugated antibodies, and dead cells were excluded using 2 μg/ml propidium iodide (PI, #P1304MP, Invitrogen). Cells were acquired using FACScan equipped with CellQuest software version 3.1 (BD Biosciences) and the proportions of the different fractions were calculated as a percentage of total live cells.
+ Open protocol
+ Expand
2

Xenograft Mouse Model for CAR T Cell Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animal studies were approved by the state animal research committee (LANUV, NRW, Germany) and all animals were cared for according to the guidelines set by the Federation of European Laboratory Animal Science Associations. Six- to 8-week-old female NOD.Cg-PrkdcSCIDIl2rgtm1Wjl/SzJ (NOD-SCID gamma; NSG) mice (Charles River Laboratories, Sulzfeld, Germany) were intravenously engrafted with 3.5 × 106 MOLM-14 cells stably expressing a firefly luciferase-EGFP fusion protein (LucEG). Six days later, mice were intravenously injected with 3.5 × 106 N3-, N4-, or CD8-hinged CD19 or CD33 CAR T cells. At days 6, 13, 20, 27, and 34, the persistence of MOLM-14 cells was assessed via luminescence imaging and PB analysis. For luminescence imaging, mice were intraperitoneally injected with D-luciferin (OZ Biosciences SAS, Marseilles, France) and after 5 min luminescence was measured in a Caliper IVIS Lumina II system (PerkinElmer LAS, Rodgau, Germany) with an exposure time of 15 s. PB was drawn from the tail vein, the erythrocytes lysed with BD Pharm Lyse (BD Biosciences), and the samples analyzed on a MACSQuant Analyzer X flow cytometer for EGFP, CD33, and CD45 expression for MOLM-14 cells and BFP, CAR (ΔNGFR), CD3, and CD45 expression for CAR T cells after staining with CD271-PE, CD3-PerCP-Vio700, CD45-APC, and CD33-APC-Vio770 (all from Miltenyi Biotec)
+ Open protocol
+ Expand
3

Evaluation of CSCs-like Cell Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the evaluation of CSCs-like cell surface markers, the following fluorochrome-conjugated antibodies were used: CD24-PE, CD26-PE, CD44-PE/CD44-APC, CD133-PE/CD133-APC, CD271-PE, EpCAM-PE (Miltenyi Biotec, Bergisch Gladbach, Germany), CD166-PE (ALCAM, Immunotech, France), and cMET-APC (R&D Systems, Abingdon, UK). Dead cells were excluded from the analysis based on DAPI staining. Cells were analyzed by BD FACSCanto™ II flow cytometer (Beckton Dickinson, USA) equipped with FacsDiva program. FCS Express software was used for the evaluation.
+ Open protocol
+ Expand
4

Multiparameter Flow Cytometry of ASCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
ASCs, with and without 50% OA-SF, were analyzed by flow cytometry with a CytoFLEX flow cytometer (Beckman Coulter, Fullerton, CA, USA), collecting at least 50,000 events. Antibodies: anti-CD90-FITC (REA897, Miltenyi Biotec, Bergisch Gladbach, Germany), CD73-PE (REA804, Miltenyi), CD105-PerCP-Cy5.5 (43A3, BioLegend, San Diego, CA, USA), CD44-PE-Vio770 (REA690, Miltenyi), CD34-FITC (AC136, Miltenyi), CD271-PE (REA844, Miltenyi), CD31-PerCP-Vio700 (REA730, Miltenyi) and CD45-PE-Vio770 (REA747, Miltenyi). Aggregates were removed from gating events on a FSC-H and FSC-A plot.
+ Open protocol
+ Expand
5

Multiparameter Flow Cytometry Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were washed with PBS and stained at room temperature using a 1:10 dilution of the indicated antibodies in 100 µL PBS for 10 min. Cells were washed once more to remove antibody excess and flow cytometry data was subsequently acquired with FACSCalibur (BD Biosciences, Franklin Lakes, NJ, USA). Live cells were gated based on forward and side scatter plots. Isotype staining’s were performed as control conditions. Anti-CTLA-4 PE extracellular antibody, anti-Gal-9-PE and their corresponding isotype controls were purchased from Biolegend, San Diego, CA, USA. The rest of the antibodies (anti-CD276-PE, anti-CD80-PE, anti-CD86-APC, anti-CD273-PE, anti-CD274-APC, anti-HLA-E-APC, anti-CD112-PE, anti-CD66abce-APC, anti-CD155-PE, anti-CD19-APC or FITC, anti-PD1-PE, anti-TIM3-APC, anti-NKG2A-FITC, CD56-APC, CD96-APC, TIGIT-PE, CD34-APC, CD271-PE and corresponding isotype controls) were obtained from Miltenyi Biotec, Bergisch Gladbach, Germany. CD19-CAR and CD276-CAR expression on NK-92 cells was determined by CD271 and CD34 marker gene expression, respectively, whereas luciferase expression on target cells was correlated with GFP for Nalm-6 GFP/Luc and CD19 marker expression for U-937 CD19tag/Luc.
+ Open protocol
+ Expand
6

Flow Cytometry Analysis of oBMSC

Check if the same lab product or an alternative is used in the 5 most similar protocols
For flow cytometry analysis, oBMSC were stained with the following anti-human antibodies: CD34-APC, CD90-FITC, CD73-APC, CD105-PE, CD146-APC, CD271-PE, HLA-DR-PE, and isotype controls (Miltenyi Biotec). Additionally, the following anti-sheep antibodies were used: CD45-FITC and CD44-FITC (Bio-Rad). Cells were stained as per the manufacturers’ instructions, and analysis was completed using an LSR II flow cytometer (BD Biosciences). In this analysis, we also included sheep bone marrow mononuclear cells (MNC) and hBMSC. These cell populations served as controls for antibody performance against a common hBMSC population, and for sheep MNC, where haematopoietic cells (CD45+) would be expected. Data were analysed using FlowJo software, version 10 (BD Biosciences).
+ Open protocol
+ Expand
7

Immunofluorescence Microscopy Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
IF was performed as reported previously.23 (link) Incubation with primary antibodies CD271-PE (Miltenyi, Bergisch Gladbach, Germany, clone ME20.4-1.H4, mouse IgG1, 1:100), γH2AX (1:250, Cell Signaling Technology), NFκB/p65 and p53 (Cell Signaling Technology, 1:100) or TRITC-labeled phalloidin (1:1000, Sigma-Aldrich) diluted in blocking buffer was done overnight at 4 °C. Second day, cells were washed 3x with phosphate-buffered saline, and incubated with secondary antibodies AlexaFluor488/555 or 594 (1:500) recognizing either rabbit or mouse-produced antibodies and 4′,6-diamidin-2-phenylindol (Sigma-Aldrich, 1:500) for 1 h at room temperature. Washed cells were covered with 500 μl phosphate-buffered saline and used for microscopy. IF pictures were recorded with Zeiss Axiovert40CFL with accompanied Illuminator HPX120C and software AxioVision Rel. 4.8 (all Carl Zeiss AG, Oberkochen, Germany).
+ Open protocol
+ Expand
8

Comprehensive Immunophenotyping of Cell Populations

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following fluorochrome-conjugated antibodies were used for the evaluation of surface markers: CD44-PE, CD24-PE, CD26-PE, CD271-PE, CD133/2-PE (Miltenyi Biotec, Germany); CD166-PE (ALCAM; Immunotech, France); CD274 (PD-L1; Sony Biotechnology, USA); CD44v6-PE (RD Systems, USA); CD184 (CXCR4-PE; eBioscience, USA). Dead cells were excluded from the analysis based on DAPI staining. Cells were analyzed using BD FACSCanto™ II flow cytometer (Beckton Dickinson, USA) equipped with FacsDiva program. FCS Express software was used for the evaluation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!